Singapore PM Lee tests positive for Covid positive again in rebound case, says he feels fine

Singapore PM Lee tests positive for Covid positive again in rebound case, says he feels fine


Singapore Prime Minister Lee Hsien Loong has tested positive again for Covid-19 Thursday, a week and a half after his initial diagnosis, in what his doctors say is a case of rebound infection.

Martin Ollman | Getty Images News | Getty Images

SINGAPORE — Singapore Prime Minister Lee Hsien Loong has tested positive again for Covid-19 a week and a half after his initial diagnosis, in what his doctors said is a case of rebound infection.

“I feel fine but I am afraid I have turned COVID-19 positive again,” Lee said Thursday on social media. “My doctors say it is a Covid rebound, which happens in 5-10% of cases. It is still infectious although the risk is not high compared to the initial infection.”

As a result, Lee missed the consecration ceremony of a Hindu temple in Singapore. His reinfection comes as Singapore prepares to host top defense leaders from Asia Pacific at this weekend’s Shangri-La Dialogue, including China defense minister, Gen. Li Shangfu, U.S. Secretary of Defense Lloyd Austin and Australian Prime Minister Anthony Albanese.

Lee, who is 71-years-old, was prescribed the antiviral medication Paxlovid when he first tested positive on May 22 after returning from a six-day official working trip to South Africa and Kenya. He has been serving as prime minister of the Southeast Asian city-state since 2004.

Singapore is coming off an April peak in Covid-19 infections and its government has been lauded for its largely effective handling of the pandemic.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Healthy Returns: What to expect from pharma at the JPM conference
Health

Healthy Returns: What to expect from pharma at the JPM conference

Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard Lutnick listen while U.S. President Donald Trump announces a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White […]

Read More
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Health

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Europe’s best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts say could be worth as much as $23 billion. Abivax, the French clinical-stage biotech company developing a treatment for ulcerative colitis and Crohn’s disease, saw shares rocket 1,681% last year, far outpacing the Stoxx 600 […]

Read More
Patient advocacy groups urge U.S. court to halt overseas prescription drug operations
Health

Patient advocacy groups urge U.S. court to halt overseas prescription drug operations

In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York. Spencer Platt | Getty Images News | Getty Images A coalition of patient advocacy groups is urging a federal court to halt the practices of third-party companies that buy drugs from countries outside the FDA-regulated […]

Read More